BLRX logo

BioLineRx (BLRX) Company Overview

Profile

Full Name:

BioLineRx Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

July 27, 2011

Indexes:

Not included

Description:

BioLineRx (BLRX) is a biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. They aim to advance their drug candidates through clinical trials, targeting unmet medical needs and improving patient outcomes with novel treatments.

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 25, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 30, 2025

Analyst ratings

Recent major analysts updates

Nov 25, 24 HC Wainwright & Co.
Buy
Nov 6, 24 HC Wainwright & Co.
Buy
Jun 3, 24 HC Wainwright & Co.
Buy
May 29, 24 HC Wainwright & Co.
Buy
Apr 17, 24 HC Wainwright & Co.
Buy
Mar 26, 24 HC Wainwright & Co.
Buy
Feb 29, 24 HC Wainwright & Co.
Buy
Nov 20, 23 HC Wainwright & Co.
Buy
Sep 15, 23 HC Wainwright & Co.
Buy
Aug 31, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for BioLineRx?
  • Does BioLineRx pay dividends?
  • What sector is BioLineRx in?
  • What industry is BioLineRx in?
  • What country is BioLineRx based in?
  • When did BioLineRx go public?
  • Is BioLineRx in the S&P 500?
  • Is BioLineRx in the NASDAQ 100?
  • Is BioLineRx in the Dow Jones?
  • When was BioLineRx's last earnings report?
  • When does BioLineRx report earnings?
  • Should I buy BioLineRx stock now?

What is the ticker symbol for BioLineRx?

The ticker symbol for BioLineRx is NASDAQ:BLRX

Does BioLineRx pay dividends?

No, BioLineRx does not pay dividends

What sector is BioLineRx in?

BioLineRx is in the Healthcare sector

What industry is BioLineRx in?

BioLineRx is in the Biotechnology industry

What country is BioLineRx based in?

BioLineRx is headquartered in Israel

When did BioLineRx go public?

BioLineRx's initial public offering (IPO) was on July 27, 2011

Is BioLineRx in the S&P 500?

No, BioLineRx is not included in the S&P 500 index

Is BioLineRx in the NASDAQ 100?

No, BioLineRx is not included in the NASDAQ 100 index

Is BioLineRx in the Dow Jones?

No, BioLineRx is not included in the Dow Jones index

When was BioLineRx's last earnings report?

BioLineRx's most recent earnings report was on Nov 25, 2024

When does BioLineRx report earnings?

The next expected earnings date for BioLineRx is Mar 26, 2025

Should I buy BioLineRx stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions